Mental Health
New kind of schizophrenia drug aces human trial
KarXT, a new schizophrenia treatment that addresses a wider range of symptoms than existing meds, has aced a phase 3 trial.
The Biden administration is preparing for legal psychedelics within two years
The Biden administration’s Department of Health and Human Services has sent a memo supportive of psychedelic therapies. What does that mean for the field?
ADHD drugs might also treat Alzheimer’s disease
Scientists reviewed 40 years of clinical studies that assessed the effects of NA-targeting drugs, such as certain ADHD drugs, on Alzheimer’s.
How natural “short sleepers” thrive on 4 hours of sleep per night
Natural "short sleepers" thrive on only four to six hours of sleep per night. Could their genetics explain why?
Your genes may impact psychedelic experiences
UNC researchers have found evidence that the genetic makeup of a crucial receptor may impact your psychedelic experience.
Widom of Daoism: why Yin-Yang is so much more than a tattoo
Yin-Yang symbolizes not a conflict or struggle but shows that nothing in life is solely either this or that.
Nurturing dads raise emotionally intelligent kids
Nurturing dads raise more emotionally intelligent children, helping make society more respectful and equitable.
The Four Enemies to a happy life and how to defeat them
Buddhist psychologists, Robert Thurman and Sharon Salzberg, have identified "Four Enemies" that are obstacles to a happy, fulfilled life.
The first FDA-approved clinical trial of psilocin has begun
“This has never been done before,” says Filament’s CEO.
Psychedelic research returns to Veterans Affairs
After decades, the Department of Veterans Affairs is once again investigating psychedelic therapies.